About the Child Vaccination Schedule Calculator
This tool generates a personalized childhood immunization schedule based on the CDC 2024 recommended vaccine schedule, endorsed by the Advisory Committee on Immunization Practices (ACIP), the American Academy of Pediatrics (AAP), and the American Academy of Family Physicians (AAFP). Enter your child's date of birth and the calculator will calculate the approximate target date for every recommended dose from birth through age 16, color-coded by whether each dose is past due, due now, or upcoming.
Why vaccines matter: herd immunity and disease elimination
Vaccines protect not just the individual child, but entire communities. When a high enough proportion of a population is immune to a disease — through vaccination or prior infection — the pathogen cannot sustain chains of transmission. This is called herd immunity, or community immunity. The threshold varies by disease: measles requires roughly 95% vaccination coverage because it is extraordinarily contagious (one infected person can infect 12–18 susceptibles). Polio requires around 80–85%. When coverage drops below those thresholds, outbreaks can spread rapidly, particularly among those who cannot be vaccinated — newborns too young for certain vaccines, immunocompromised children undergoing chemotherapy, and individuals with rare contraindications.
The history of vaccine-preventable diseases is a compelling argument for the schedule. In the pre-vaccine era, measles infected nearly every child in the United States — roughly 3–4 million cases per year, causing about 400–500 deaths and 48,000 hospitalizations annually. After the measles vaccine was licensed in 1963, cases fell more than 99%. Polio paralyzed tens of thousands of Americans each year in the early 1950s; the United States has been polio-free since 1979. Haemophilus influenzae type b (Hib) was the leading cause of bacterial meningitis in children under 5 before its vaccine; the Hib vaccine has eliminated this disease in vaccinated populations by more than 99%. These are not marginal improvements — they represent some of the most dramatic successes in public health history.
How the CDC schedule is developed: the ACIP process
The immunization schedule is not written by a single agency or company. It is developed through a rigorous, multi-stakeholder process led by the Advisory Committee on Immunization Practices (ACIP), a 15-member federal advisory committee of immunization experts that meets three times per year. The process works as follows:
- Clinical trial data: Vaccine manufacturers must complete Phase III trials demonstrating safety and efficacy before FDA approval. ACIP reviews this data independently.
- Work group review: For each vaccine, ACIP forms a working group of experts who review published literature, unpublished data, post-licensure surveillance, and economic analyses over months or years.
- Evidence grading: ACIP uses an evidence-grading framework adapted from other medical specialty societies to categorize the strength of evidence behind each recommendation.
- Public comment: Proposed changes to the schedule are published in the Federal Register for public comment before final votes.
- Annual publication: ACIP publishes updated schedules each January in Morbidity and Mortality Weekly Report (MMWR) and the journal Pediatrics.
Once ACIP votes, the CDC Director accepts or rejects the recommendation. AAP and AAFP may endorse with minor modifications. The process typically takes 18 months to several years from initial evidence review to final schedule recommendation.
Common vaccine hesitancy concerns and evidence-based responses
Vaccine hesitancy — a delay in or refusal of vaccines despite their availability — is one of the top ten global health threats identified by the World Health Organization. Understanding the concerns and the evidence is important for informed decision-making.
"My child's immune system is overwhelmed by so many vaccines at once." This concern is understandable but not supported by immunology. An infant's immune system encounters thousands of bacteria, viruses, and other antigens every day through normal breathing and touching. The antigens in the entire recommended vaccine schedule represent a tiny fraction of what the immune system processes daily. A landmark 2002 study estimated that infants have the theoretical capacity to respond to 10,000 vaccines simultaneously.
"Natural infection provides better immunity than vaccination." For some diseases, natural infection does produce stronger or more durable immunity. However, natural infection carries the full risk of the disease itself — encephalitis from measles, paralysis from polio, liver failure from hepatitis B. Vaccination produces immunity while bypassing the dangerous disease.
"Vaccines contain dangerous chemicals." Vaccine ingredients are held to strict safety standards. Formaldehyde, sometimes cited as dangerous, is present in trace amounts in some vaccines and is also produced naturally by the human body during normal metabolism — the amount in blood from natural processes vastly exceeds what is in any vaccine. Thimerosal (ethylmercury), which was removed from childhood vaccines (except multi-dose influenza vials) by 2001 as a precaution, has been studied extensively with no evidence of harm at vaccine doses.
Catch-up vaccination schedules
The schedule shown by this calculator reflects on-time doses starting at birth. Children who fall behind can often catch up, but the intervals between catch-up doses may differ from the routine schedule. The CDC publishes a dedicated catch-up immunization schedule for children aged 4 months through 18 years. Key principles include:
- Generally, you do not need to restart a vaccine series — even if doses are years apart. Any valid dose already given counts.
- Minimum intervals between doses must be respected. Giving doses too close together may result in an invalid dose that must be repeated.
- Combination vaccines (e.g., MMRV for measles-mumps-rubella-varicella, or Pediarix for DTaP-HepB-IPV) can reduce the number of injections during catch-up.
- Children who were never vaccinated need a full primary series, which often compresses the standard schedule into a shorter catch-up timeline.
Always consult a pediatrician or public health clinic for a specific catch-up plan — the official catch-up tables are complex and individualized.
Travel vaccines
International travel may require vaccines beyond the routine childhood schedule. Common travel-related vaccines include:
- Typhoid: Recommended for travel to endemic areas in South Asia, Southeast Asia, Africa, and Latin America.
- Yellow fever: Required by some countries as a condition of entry. Live vaccine; not for infants under 9 months.
- Japanese encephalitis: For extended travel to rural parts of Asia.
- Rabies pre-exposure prophylaxis: For children with high exposure risk (outdoor activities, animal contact in endemic countries).
- Meningococcal ACWY or B: Required for Hajj pilgrimage; recommended for sub-Saharan Africa travel.
Plan travel vaccines at least 4–6 weeks before departure. Some vaccines require multiple doses over weeks or months. A travel medicine clinic or pediatrician experienced in travel health can assess the specific itinerary and age of the child.
School vaccination requirements by state
Every U.S. state requires certain vaccinations for school entry, though the specific requirements, grade levels, and exemption policies vary. Most states require proof of DTaP, MMR, polio, varicella, and hepatitis B vaccines for kindergarten entry. Many states have added Hib, hepatitis A, meningococcal, and HPV requirements at various grade levels. All states allow medical exemptions. Some states allow philosophical or religious exemptions, though the process varies widely. Check your specific state's Department of Health website for current requirements, as they are updated regularly. The CDC maintains a summary of state school vaccination requirement laws.
What to do if a dose is missed
Missing a dose does not mean starting over. The key steps when a vaccine is missed:
- Record the date each dose was given. Most pediatricians maintain immunization records and upload them to the state immunization information system (IIS).
- Identify which doses are overdue using the current catch-up schedule from the CDC website.
- Schedule the overdue vaccines as soon as possible — do not wait for the next well-child visit if several months away.
- Ensure minimum intervals are met. The catch-up schedule tables specify minimum intervals; if a dose is given too early, it may not count and need to be repeated.
- Update the immunization record after each appointment.
VAERS and vaccine safety monitoring
The United States operates one of the world's most extensive vaccine safety monitoring systems:
- VAERS (Vaccine Adverse Event Reporting System): A national passive surveillance system co-managed by CDC and FDA. Anyone — a patient, parent, or healthcare provider — can report any adverse event after vaccination. VAERS is designed to detect safety signals, not to determine causation. A report to VAERS does not mean a vaccine caused the event.
- Vaccine Safety Datalink (VSD): A CDC-managed network of eight integrated health care organizations covering over 12 million people. VSD conducts rapid-cycle analyses comparing adverse event rates in vaccinated versus unvaccinated individuals using electronic health records.
- Clinical Immunization Safety Assessment (CISA) Project: Conducts clinical research on complex vaccine safety questions referred by healthcare providers through CDC.
- Post-licensure Rapid Immunization Safety Monitoring (PRISM): FDA-managed system using insurance claims data to monitor vaccine safety across millions of individuals.
These overlapping systems have detected rare adverse events that were not apparent in pre-licensure trials. For example, the original RotaShield rotavirus vaccine was withdrawn in 1999 after VSD detected a small increase in intussusception risk. The current rotavirus vaccines have been confirmed safe through extensive post-licensure monitoring.
Frequently Asked Questions
Why are so many vaccines given at the same time?
What if my child missed a vaccine?
Are childhood vaccines safe?
Do vaccines cause autism?
Reference Tables
Table 1: Vaccines, diseases prevented, and number of doses
| Vaccine | Diseases Prevented | Standard Doses (birth–18 yr) |
|---|---|---|
| Hepatitis B (HepB) | Hepatitis B (liver disease, liver cancer) | 3 |
| Rotavirus (RV) | Rotavirus gastroenteritis (severe diarrhea) | 2–3 (brand-dependent) |
| DTaP / Tdap | Diphtheria, tetanus, pertussis (whooping cough) | 5 (DTaP) + 1 (Tdap booster) |
| Hib | Haemophilus influenzae type b disease (meningitis, epiglottitis) | 3–4 (brand-dependent) |
| PCV15 / PCV20 | Pneumococcal disease (pneumonia, meningitis, blood infections) | 4 |
| IPV | Poliomyelitis (polio, paralysis) | 4 |
| Influenza | Seasonal influenza | Annual (2 doses first year, then 1/year) |
| MMR | Measles, mumps, rubella | 2 |
| Varicella | Chickenpox (varicella) | 2 |
| Hepatitis A (HepA) | Hepatitis A (liver disease) | 2 |
| Meningococcal (MenACWY) | Meningococcal disease (meningitis, septicemia) | 2 (dose + booster) |
| HPV | Human papillomavirus (cervical, throat, and other cancers) | 2 (if started before 15); 3 (if started at 15+) |
| COVID-19 | COVID-19 | Annual (starting 6 months) |
Table 2: Age milestones and vaccines due
| Age Milestone | Vaccines Due |
|---|---|
| Birth | Hepatitis B (Dose 1) |
| 1–2 months | Hepatitis B (Dose 2) |
| 2 months | DTaP, Hib, PCV, IPV, Rotavirus (all Dose 1) |
| 4 months | DTaP, Hib, PCV, IPV, Rotavirus (all Dose 2) |
| 6 months | DTaP, Hib, PCV, IPV, Rotavirus, HepB, Influenza, COVID-19 (Dose 3 / first annual) |
| 12–15 months | MMR, Varicella, HepA (Dose 1), Hib (booster), PCV (booster) |
| 18 months | Hepatitis A (Dose 2), DTaP (Dose 4) |
| 4–6 years | DTaP (Dose 5), MMR (Dose 2), Varicella (Dose 2), IPV (Dose 4) |
| 11–12 years | Tdap, MenACWY (Dose 1), HPV (Dose 1 & 2) |
| 16 years | MenACWY (Booster) |
Table 3: Vaccine-preventable disease incidence before and after vaccine introduction
| Disease | Pre-vaccine Peak (annual U.S. cases) | Recent Annual Cases | Vaccine Year |
|---|---|---|---|
| Measles | ~894,000 (1941) | <200 | 1963 |
| Polio (paralytic) | ~21,000 (1952) | 0 (endemic) | 1955 |
| Diphtheria | ~206,000 (1921) | <5 | 1920s (toxoid) |
| Whooping cough (pertussis) | ~265,000 (1934) | ~15,000–20,000 | 1940s |
| Mumps | ~186,000 (1968) | ~1,000–5,000 | 1967 |
| Rubella | ~57,000 (1969) | <10 | 1969 |
| Hib disease (children <5) | ~20,000 (1980s) | <50 | 1987–1993 |
| Hepatitis B | ~260,000/yr (early 1980s) | ~20,700 | 1982 |
| Chickenpox (varicella) | ~4 million (early 1990s) | ~350,000 | 1995 |
| Rotavirus hospitalizations (children) | ~55,000/yr (pre-2006) | ~15,000 | 2006 |